To: President Donald Trump, The United States House of Representatives, and The United States Senate

STOP: Gilead Sciences Price-Gouging Hepatitis C Patients

You have the power to enact legislation to stop Gilead Sciences from gouging hepatitis C patients at $1,000 per pill for 12 weeks. The HCV community needs funding for awareness and access to treatment.

Why is this important?

Hepatitis C nearly killed me. In 2014, I received a liver transplant. I was fortunate to have an insurance plan that paid for all of my related healthcare, as well as the Sovaldi-based medicine that cured my HCV infection. Over 3 million Americans are infected, most of them unable to afford Gilead Sciences $1,000 per pill price.